The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 31, 2022
Filed:
Dec. 23, 2020
Bayer Pharma Aktiengesellschaft, Berlin, DE;
Bayer Aktiengesellschaft, Leverkusen, DE;
Anke Stroyer, Berlin, DE;
Carmen Lobback, Schöneiche, DE;
Peter Serno, Bergish Gladbach, DE;
Philipp Rubenbauer, Bensheim, DE;
Kai Lovis, Düsseldorf, DE;
Heiko Schirmer, Solingen, DE;
Danja Grossbach, Wuppertal, DE;
Donald Bierer, Haan, DE;
Britta Olenik, Bottrop, DE;
Tia Jacobs, Wuppertal, DE;
Julia Küsel, Bochum, DE;
BAYER PHARMA AKTIENGESELLSCHAFT, Berlin, DE;
BAYER AKTIENGESELLSCHAFT, Leverkusen, DE;
Abstract
The present invention relates to orally administrable modified-release pharmaceutical dosage forms comprising sodium (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate and to processes for preparing the dosage forms and to their use for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiac, renal and pulmonary disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic disorders.